# FDA recall D-0691-2017

> **Meridian Medical Technologies a Pfizer Company** · Class I · drug recall initiated 2017-03-12.

## Product

EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS:  Epipen Auto-Injector Jr. 0.15 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.

## Reason for recall

Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

## Distribution

Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand,  United Kingdom.  There has been no U.S. government or military distribution.

## Key facts

- **Recall number:** D-0691-2017
- **Recalling firm:** Meridian Medical Technologies a Pfizer Company
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2017-03-12
- **Report date:** 2017-05-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Brentwood, MO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0691-2017

## Citation

> AI Analytics. FDA recall D-0691-2017. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-0691-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*